These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
143 related articles for article (PubMed ID: 6856560)
1. [Serum theophylline steady-state levels: comparative study of 2 retard preparations]. Kaukel E; Koppermann G Prax Klin Pneumol; 1983 Mar; 37(3):109-12. PubMed ID: 6856560 [No Abstract] [Full Text] [Related]
2. A controlled study of slow-release theophylline and aminophylline in patients with chronic bronchitis. Jenkins PF; White JP; Jariwalla AJ; Anderson G; Campbell IA Br J Dis Chest; 1982 Jan; 76(1):57-60. PubMed ID: 7037034 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of Euphylline-retard based on the measurement of theophylline concentration in the blood serum and spirometric parameters]. Pietruszewska E; Droszcz W; Wrońska J; Kowalski J Pneumonol Pol; 1981 Nov; 49(11):783-9. PubMed ID: 7342049 [No Abstract] [Full Text] [Related]
4. [A dose-concentration relationship study in different dosage regimens for theophylline preparations: intravenous for euphylline and peroral for prolonged-action forms]. Tsoĭ AN; Bogovskiĭ BP; Gavrilenko LN; Kushkenbaeva BE; Kukes VG Ter Arkh; 1990; 62(9):22-5. PubMed ID: 2281401 [No Abstract] [Full Text] [Related]
5. [Comparison of 2 theophylline delayed-action preparations of different galenic forms]. Hirsch H Wien Med Wochenschr; 1983 Aug; 133(15-16):403-8. PubMed ID: 6636797 [TBL] [Abstract][Full Text] [Related]
6. [Possibilities for optimizing therapy with theophylline preparations. I. On the pharmacokinetics of theophylline preparations]. Wiesner B; Sehrt I; Iwainsky H Z Erkr Atmungsorgane; 1984; 162(1):3-10. PubMed ID: 6719957 [TBL] [Abstract][Full Text] [Related]
8. Comparison of aminophylline and theophylline sustained-release formulations by their bioavailability and steady-state serum levels. Steinijans VW; Zech K; Fischer R Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):624-30. PubMed ID: 6668100 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels. van der Vet AP; Drost RH; Kreukniet J; Maes RA Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (Theograd, 350 mg Theolair Retard, and 300 mg Theolin Retard) in steady state in six normals and six patients with chronic asthmatic bronchitis--Part II: Lung function. van der Vet AP; Kreukniet J; Drost RH; Maes RA Int J Clin Pharmacol Ther Toxicol; 1985 Jul; 23(7):339-44. PubMed ID: 4030161 [TBL] [Abstract][Full Text] [Related]
12. Comparison of serum theophylline levels with plain and slow-release aminophylline in patient with airway obstruction. Muittari A; Allonen H J Int Med Res; 1981; 9(5):378-80. PubMed ID: 7028535 [No Abstract] [Full Text] [Related]
13. [Comparative examination of theophylline-serum-concentrations and bronchospasmolytic effect of cholintheophyllinate (euspirax) and theophyllin-aethylendiamine (euphyllin retard) in patients with obstructive airway diseases (author's transl)]. Wettengel R; Oellerich M; Schnitker J Prax Klin Pneumol; 1979 Nov; 33(11):1125-31. PubMed ID: 523424 [TBL] [Abstract][Full Text] [Related]
20. [Comparative subacute study of the effects and side effects of a non-depot theophylline preparation (Euspirax) and a depot preparation (Euphyllin retard)--a contribution to long-term therapy of asthma]. Eitner L; Wettengel R; Schnitker J Prax Klin Pneumol; 1983 Jun; 37(6):236-42. PubMed ID: 6889277 [No Abstract] [Full Text] [Related] [Next] [New Search]